Tomokazu Oyama Selected Research

Tomokazu Oyama Research Topics

Disease

14	Type 2 Diabetes Mellitus (MODY) 01/2011 - 01/2004
6	Insulin Resistance 06/2010 - 09/2004
4	Obesity 03/2013 - 09/2004
4	Body Weight (Weight, Body) 05/2009 - 09/2004
3	Atherosclerosis 10/2010 - 04/2008
3	Hypertension (High Blood Pressure) 10/2009 - 12/2006
3	Hypercholesterolemia 10/2008 - 01/2004
3	Diabetes Mellitus 04/2008 - 06/2006
2	Albuminuria 01/2013 - 02/2006
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2013 - 02/2006
2	Hyperglycemia 01/2011 - 09/2006
1	Weight Loss (Weight Reduction) 03/2013
1	Heart Failure 01/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2008
1	Obstructive Jaundice (Cholestatic Jaundice) 10/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2007
1	Arteriosclerosis 06/2006

Drug/Important Bio-Agent (IBA)

8	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 06/2010 - 01/2004
5	Glucose (Dextrose)FDA LinkGeneric 10/2007 - 09/2004
3	Probucol (Lorelco)FDA Link 01/2013 - 02/2006
3	oxidized low density lipoproteinIBA 10/2010 - 06/2006
3	Angiotensin Receptor AntagonistsIBA 10/2009 - 06/2006
2	AlbuminsIBA 01/2013 - 02/2006
2	Insulin (Novolin)FDA Link 01/2011 - 04/2006
2	CholesterolIBA 10/2010 - 10/2008
2	Angiotensin IIIBA 06/2010 - 05/2009
2	Amlodipine (Norvasc)FDA LinkGeneric 10/2009 - 10/2009
2	CarbohydratesIBA 10/2007 - 09/2004
2	AdiponectinIBA 10/2007 - 04/2007
2	8-Hydroxy-2'-DeoxyguanosineIBA 09/2006 - 02/2006
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2006 - 01/2004
2	Atorvastatin (Lipitor)FDA Link 02/2006 - 01/2004
1	CreatinineIBA 01/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2011
1	insulin aspart protamine drug combination 30:70 insulin aspartIBA 01/2011
1	Biphasic InsulinsIBA 01/2011
1	Ezetimibe (Zetia)FDA Link 10/2010
1	LDL CholesterolIBA 10/2010
1	Pioglitazone (Actos)FDA Link 06/2010
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2009
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 10/2009
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2009
1	Calcium Channels (Calcium Channel)IBA 10/2009
1	olmesartanIBA 10/2009
1	pitavastatin (itavastatin)FDA Link 10/2009
1	efonidipineIBA 10/2009
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2009
1	LeptinIBA 05/2009
1	Hemoglobin AIBA 05/2009
1	Apolipoproteins B (ApoB)IBA 10/2008
1	Lipoproteins (Lipoprotein)IBA 10/2008
1	Glycoside Hydrolase InhibitorsIBA 06/2008
1	Acarbose FDA LinkGeneric 06/2008
1	7-ketocholesterolIBA 04/2008
1	OxysterolsIBA 04/2008
1	Metformin (Glucophage)FDA LinkGeneric 10/2007
1	HDL CholesterolIBA 04/2007
1	Triglycerides (Triacylglycerol)IBA 04/2007
1	Biomarkers (Surrogate Marker)IBA 04/2007
1	Valsartan (Vals)FDA Link 12/2006
1	Caspase 3 (Caspase-3)IBA 09/2006
1	benidipine hydrochlorideIBA 06/2006
1	CalciumIBA 06/2006
1	candesartan cilexetil (Amias)FDA Link 06/2006
1	Isophane Insulin (NPH Insulin)FDA Link 04/2006
1	Proteins (Proteins, Gene)FDA Link 09/2004
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2004
1	Coenzyme A (CoA)IBA 01/2004
1	Oxidoreductases (Dehydrogenase)IBA 01/2004
1	Heparin (Liquaemin)FDA LinkGeneric 01/2004

Therapy/Procedure

5	Therapeutics 03/2013 - 04/2006
1	Aftercare (After-Treatment) 01/2013
1	Renal Dialysis (Hemodialysis) 01/2013
1	Reducing Diet 05/2009
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 09/2004
1	Caloric Restriction 09/2004